Stratos Wealth Partners’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16K | Buy |
29,540
+10,000
| +51% | +$5.41K | ﹤0.01% | 1413 |
|
|
2025
Q1 | $12.8K | Hold |
19,540
| – | – | ﹤0.01% | 1354 |
|
|
2024
Q4 | $19.9K | Buy |
19,540
+4,000
| +26% | +$4.08K | ﹤0.01% | 1442 |
|
|
2024
Q3 | $13.5K | Buy |
+15,540
| New | +$13.5K | ﹤0.01% | 1430 |
|
|
2020
Q4 | – | Sell |
-12,111
| Closed | -$114K | – | 1112 |
|
|
2020
Q3 | $114K | Sell |
12,111
-465
| -4% | -$4.38K | ﹤0.01% | 963 |
|
|
2020
Q2 | $113K | Buy |
12,576
+685
| +6% | +$6.16K | ﹤0.01% | 946 |
|
|
2020
Q1 | $76K | Sell |
11,891
-376
| -3% | -$2.4K | ﹤0.01% | 884 |
|
|
2019
Q4 | $103K | Sell |
12,267
-100
| -0.8% | -$840 | ﹤0.01% | 950 |
|
|
2019
Q3 | $112K | Buy |
+12,367
| New | +$112K | ﹤0.01% | 922 |
|
|
2018
Q4 | – | Sell |
-3,754
| Closed | -$64K | – | 2216 |
|
|
2018
Q3 | $64K | Buy |
+3,754
| New | +$64K | ﹤0.01% | 1347 |
|
|
2018
Q2 | – | Sell |
-2,909
| Closed | -$55K | – | 2296 |
|
|
2018
Q1 | $55K | Sell |
2,909
-5
| -0.2% | -$95 | ﹤0.01% | 1527 |
|
|
2017
Q4 | $48K | Buy |
+2,914
| New | +$48K | ﹤0.01% | 1533 |
|